3.03
-0.04(-1.30%)
Currency In USD
| Previous Close | 3.07 |
| Open | 3.07 |
| Day High | 3.12 |
| Day Low | 3.02 |
| 52-Week High | 10.48 |
| 52-Week Low | 1.6 |
| Volume | 98,921 |
| Average Volume | 277,090 |
| Market Cap | 116.9M |
| PE | -1.94 |
| EPS | -1.56 |
| Moving Average 50 Days | 3.16 |
| Moving Average 200 Days | 3.86 |
| Change | -0.04 |
If you invested $1000 in Protara Therapeutics, Inc. (TARA) 10 years ago, it would be worth $5.02 as of September 17, 2025 at a share price of $3.03. Whereas If you bought $1000 worth of Protara Therapeutics, Inc. (TARA) shares 5 years ago, it would be worth $155.38 as of September 17, 2025 at a share price of $3.03.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Protara Therapeutics Announces Addition to the Russell 3000® Index
GlobeNewswire Inc.
Jun 30, 2025 12:00 PM GMT
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that the Company has been added as a
Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer
GlobeNewswire Inc.
Jun 02, 2025 8:04 PM GMT
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of William “Bill” Con
Protara Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
May 13, 2025 12:00 PM GMT
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in th